Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

The whole genome landscape of Burkitt lymphoma subtypes.

Panea RI, Love CL, Shingleton JR, Reddy A, Bailey JA, Moormann AM, Otieno JA, Ong'echa JM, Oduor CI, Schroeder KMS, Masalu N, Chao NJ, Agajanian M, Major MB, Fedoriw Y, Richards KL, Rymkiewicz G, Miles RR, Alobeid B, Bhagat G, Flowers CR, Ondrejka SL, Hsi ED, Choi WWL, Au-Yeung RKH, Hartmann W, Lenz G, Meyerson H, Lin YY, Zhuang Y, Luftig MA, Waldrop A, Dave T, Thakkar D, Sahay H, Li G, Palus BC, Seshadri V, Kim SY, Gascoyne RD, Levy S, Mukhopadhyay M, Dunson DB, Dave SS.

Blood. 2019 Sep 26. pii: blood.2019001880. doi: 10.1182/blood.2019001880. [Epub ahead of print]

PMID:
31558468
2.

Immune effector mechanisms in malaria: An update focusing on human immunity.

Moormann AM, Nixon CE, Forconi CS.

Parasite Immunol. 2019 Aug;41(8):e12628. doi: 10.1111/pim.12628. Epub 2019 May 9. Review.

PMID:
30972776
3.

Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas.

Forconi CS, Cosgrove CP, Saikumar-Lakshmi P, Nixon CE, Foley J, Ong'echa JM, Otieno JA, Alter G, Münz C, Moormann AM.

Blood Adv. 2018 May 22;2(10):1101-1114. doi: 10.1182/bloodadvances.2017015404.

4.

Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma.

Oduor CI, Kaymaz Y, Chelimo K, Otieno JA, Ong'echa JM, Moormann AM, Bailey JA.

BMC Cancer. 2017 Nov 13;17(1):761. doi: 10.1186/s12885-017-3711-9.

5.

High pathogen burden in childhood promotes the development of unconventional innate-like CD8+ T cells.

Falanga YT, Frascoli M, Kaymaz Y, Forconi C, Ong'echa JM, Bailey JA, Berg LJ, Moormann AM.

JCI Insight. 2017 Aug 3;2(15). pii: 93814. doi: 10.1172/jci.insight.93814. eCollection 2017 Aug 3.

6.

Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.

Kaymaz Y, Oduor CI, Yu H, Otieno JA, Ong'echa JM, Moormann AM, Bailey JA.

Mol Cancer Res. 2017 May;15(5):563-576. doi: 10.1158/1541-7786.MCR-16-0305.

7.

Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma.

Oduor CI, Movassagh M, Kaymaz Y, Chelimo K, Otieno J, Ong'echa JM, Moormann AM, Bailey JA.

Front Microbiol. 2017 Mar 28;8:501. doi: 10.3389/fmicb.2017.00501. eCollection 2017.

8.

Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study.

Parsons E, Otieno JA, Ong'echa JM, Nixon CE, Vulule J, Münz C, Stewart VA, Moormann AM.

PLoS One. 2016 Dec 29;11(12):e0167841. doi: 10.1371/journal.pone.0167841. eCollection 2016.

9.

Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis.

Moormann AM, Bailey JA.

Curr Opin Virol. 2016 Oct;20:78-84. doi: 10.1016/j.coviro.2016.09.006. Epub 2016 Sep 27. Review.

10.

Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection.

Reynaldi A, Schlub TE, Piriou E, Ogolla S, Sumba OP, Moormann AM, Rochford R, Davenport MP.

J Infect Dis. 2016 Nov 1;214(9):1390-1398. Epub 2016 Aug 28.

11.

Longevity of Genotype-Specific Immune Responses to Plasmodium falciparum Merozoite Surface Protein 1 in Kenyan Children from Regions of Different Malaria Transmission Intensity.

Bowman NM, Juliano JJ, Snider CJ, Kharabora O, Meshnick SR, Vulule J, John CC, Moormann AM.

Am J Trop Med Hyg. 2016 Sep 7;95(3):580-7. doi: 10.4269/ajtmh.15-0710. Epub 2016 Aug 1.

12.

Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study.

Buckle G, Maranda L, Skiles J, Ong'echa JM, Foley J, Epstein M, Vik TA, Schroeder A, Lemberger J, Rosmarin A, Remick SC, Bailey JA, Vulule J, Otieno JA, Moormann AM.

Int J Cancer. 2016 Sep 15;139(6):1231-40. doi: 10.1002/ijc.30170. Epub 2016 May 18.

13.

Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children.

Reynaldi A, Schlub TE, Chelimo K, Sumba PO, Piriou E, Ogolla S, Moormann AM, Rochford R, Davenport MP.

J Infect Dis. 2016 Mar 15;213(6):985-91. doi: 10.1093/infdis/jiv525. Epub 2015 Nov 3.

14.

Burkitt's Lymphoma.

Rochford R, Moormann AM.

Curr Top Microbiol Immunol. 2015;390(Pt 1):267-85. doi: 10.1007/978-3-319-22822-8_11. Review.

PMID:
26424650
15.

Does EBV alter the pathogenesis of malaria?

Matar CG, Jacobs NT, Speck SH, Lamb TJ, Moormann AM.

Parasite Immunol. 2015 Sep;37(9):433-45. doi: 10.1111/pim.12212. Review.

16.

Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.

Dent AE, Nakajima R, Liang L, Baum E, Moormann AM, Sumba PO, Vulule J, Babineau D, Randall A, Davies DH, Felgner PL, Kazura JW.

J Infect Dis. 2015 Nov 1;212(9):1429-38. doi: 10.1093/infdis/jiv224. Epub 2015 Apr 15. Erratum in: J Infect Dis. 2016 Jan 1;213(1):167.

17.

Time-to-infection by Plasmodium falciparum is largely determined by random factors.

Pinkevych M, Chelimo K, Vulule J, Kazura JW, Moormann AM, Davenport MP.

BMC Med. 2015 Jan 30;13:19. doi: 10.1186/s12916-014-0252-9.

18.

Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.

Noland GS, Jansen P, Vulule JM, Park GS, Ondigo BN, Kazura JW, Moormann AM, John CC.

Acta Trop. 2015 Feb;142:47-56. doi: 10.1016/j.actatropica.2014.10.011. Epub 2014 Oct 24.

19.

The hunt for protective correlates of immunity to Plasmodium falciparum malaria.

Moormann AM, Stewart VA.

BMC Med. 2014 Aug 8;12:134. doi: 10.1186/s12916-014-0134-1.

20.

Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study.

Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, Tagbor H, Williams J, Bojang K, Njie F, Desai M, Kariuki S, Gutman J, Mathanga DP, Mårtensson A, Ngasala B, Conrad MD, Rosenthal PJ, Tshefu AK, Moormann AM, Vulule JM, Doumbo OK, Ter Kuile FO, Meshnick SR, Bailey JA, Juliano JJ.

J Infect Dis. 2015 Mar 1;211(5):680-8. doi: 10.1093/infdis/jiu467. Epub 2014 Sep 1.

21.

Interleukin-6 and interleukin-10 gene promoter polymorphisms and risk of endemic Burkitt lymphoma.

Oduor CI, Chelimo K, Ouma C, Mulama DH, Foley J, Vulule J, Bailey JA, Moormann AM.

Am J Trop Med Hyg. 2014 Sep;91(3):649-54. doi: 10.4269/ajtmh.13-0616. Epub 2014 Jul 28.

22.

Decreased growth rate of P. falciparum blood stage parasitemia with age in a holoendemic population.

Pinkevych M, Petravic J, Chelimo K, Vulule J, Kazura JW, Moormann AM, Davenport MP.

J Infect Dis. 2014 Apr 1;209(7):1136-43. doi: 10.1093/infdis/jit613. Epub 2013 Nov 21.

23.

Factors influencing time to diagnosis and initiation of treatment of endemic Burkitt Lymphoma among children in Uganda and western Kenya: a cross-sectional survey.

Buckle GC, Collins JP, Sumba PO, Nakalema B, Omenah D, Stiffler K, Casper C, Otieno JA, Orem J, Moormann AM.

Infect Agent Cancer. 2013 Sep 30;8(1):36. doi: 10.1186/1750-9378-8-36.

24.

Density-dependent blood stage Plasmodium falciparum suppresses malaria super-infection in a malaria holoendemic population.

Pinkevych M, Petravic J, Chelimo K, Vulule J, Kazura JW, Moormann AM, Davenport MP.

Am J Trop Med Hyg. 2013 Nov;89(5):850-6. doi: 10.4269/ajtmh.13-0049. Epub 2013 Sep 9.

25.

Identification of a novel variant of LMP-1 of EBV in patients with endemic Burkitt lymphoma in western Kenya.

Wohlford EM, Asito AS, Chelimo K, Sumba PO, Baresel PC, Oot RA, Moormann AM, Rochford R.

Infect Agent Cancer. 2013 Sep 9;8(1):34. doi: 10.1186/1750-9378-8-34.

26.

Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer.

Mulama DH, Bailey JA, Foley J, Chelimo K, Ouma C, Jura WG, Otieno J, Vulule J, Moormann AM.

Int J Cancer. 2014 Feb 1;134(3):645-53. doi: 10.1002/ijc.28378. Epub 2013 Aug 16.

27.

Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites.

Moormann AM, Sumba PO, Chelimo K, Fang H, Tisch DJ, Dent AE, John CC, Long CA, Vulule J, Kazura JW.

J Infect Dis. 2013 Jul;208(1):149-58. doi: 10.1093/infdis/jit134. Epub 2013 Mar 28.

28.

Holoendemic malaria exposure is associated with altered Epstein-Barr virus-specific CD8(+) T-cell differentiation.

Chattopadhyay PK, Chelimo K, Embury PB, Mulama DH, Sumba PO, Gostick E, Ladell K, Brodie TM, Vulule J, Roederer M, Moormann AM, Price DA.

J Virol. 2013 Feb;87(3):1779-88. doi: 10.1128/JVI.02158-12. Epub 2012 Nov 21.

29.

The dynamics of naturally acquired immunity to Plasmodium falciparum infection.

Pinkevych M, Petravic J, Chelimo K, Kazura JW, Moormann AM, Davenport MP.

PLoS Comput Biol. 2012;8(10):e1002729. doi: 10.1371/journal.pcbi.1002729. Epub 2012 Oct 18.

30.

Broadly reactive antibodies specific for Plasmodium falciparum MSP-1(19) are associated with the protection of naturally exposed children against infection.

Dent AE, Moormann AM, Yohn CT, Kimmel RJ, Sumba PO, Vulule J, Long CA, Narum DL, Crabb BS, Kazura JW, Tisch DJ.

Malar J. 2012 Aug 21;11:287. doi: 10.1186/1475-2875-11-287.

31.

Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens.

Snider CJ, Cole SR, Chelimo K, Sumba PO, Macdonald PD, John CC, Meshnick SR, Moormann AM.

PLoS One. 2012;7(3):e31753. doi: 10.1371/journal.pone.0031753. Epub 2012 Mar 12. Erratum in: PLoS One. 2012;7(6): doi/10.1371/annotation/87d81085-b796-4295-9468-030300d78cd6.

32.

Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma.

Piriou E, Asito AS, Sumba PO, Fiore N, Middeldorp JM, Moormann AM, Ploutz-Snyder R, Rochford R.

J Infect Dis. 2012 Mar 15;205(6):906-13. doi: 10.1093/infdis/jir872. Epub 2012 Feb 1.

33.

Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1.

Chelimo K, Embury PB, Sumba PO, Vulule J, Ofulla AV, Long C, Kazura JW, Moormann AM.

PLoS One. 2011;6(9):e24852. doi: 10.1371/journal.pone.0024852. Epub 2011 Sep 16.

34.

The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma.

Moormann AM, Snider CJ, Chelimo K.

Curr Opin Infect Dis. 2011 Oct;24(5):435-41. doi: 10.1097/QCO.0b013e328349ac4f. Review.

35.

Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.

McCarra MB, Ayodo G, Sumba PO, Kazura JW, Moormann AM, Narum DL, John CC.

Pediatr Infect Dis J. 2011 Dec;30(12):1037-42. doi: 10.1097/INF.0b013e31822d1451.

36.

Serologic evidence of arboviral infections among humans in Kenya.

Sutherland LJ, Cash AA, Huang YJ, Sang RC, Malhotra I, Moormann AM, King CL, Weaver SC, King CH, LaBeaud AD.

Am J Trop Med Hyg. 2011 Jul;85(1):158-61. doi: 10.4269/ajtmh.2011.10-0203.

37.

Microgeographic variations in Burkitt's lymphoma incidence correlate with differences in malnutrition, malaria and Epstein-Barr virus.

Sumba PO, Kabiru EW, Namuyenga E, Fiore N, Otieno RO, Moormann AM, Orago AS, Rosenbaum PF, Rochford R.

Br J Cancer. 2010 Nov 23;103(11):1736-41. doi: 10.1038/sj.bjc.6605947.

38.

Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.

Spring MD, Chelimo K, Tisch DJ, Sumba PO, Rochford R, Long CA, Kazura JW, Moormann AM.

Infect Immun. 2010 Oct;78(10):4431-41. doi: 10.1128/IAI.00415-10. Epub 2010 Aug 9.

39.

Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study.

Asito AS, Piriou E, Odada PS, Fiore N, Middeldorp JM, Long C, Dutta S, Lanar DE, Jura WG, Ouma C, Otieno JA, Moormann AM, Rochford R.

Infect Agent Cancer. 2010 Jul 28;5:13. doi: 10.1186/1750-9378-5-13.

41.

How might infant and paediatric immune responses influence malaria vaccine efficacy?

Moormann AM.

Parasite Immunol. 2009 Sep;31(9):547-59. doi: 10.1111/j.1365-3024.2009.01137.x. Review.

42.

Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults.

Dent AE, Chelimo K, Sumba PO, Spring MD, Crabb BS, Moormann AM, Tisch DJ, Kazura JW.

Malar J. 2009 Jul 16;8:162. doi: 10.1186/1475-2875-8-162.

43.

Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya.

Piriou E, Kimmel R, Chelimo K, Middeldorp JM, Odada PS, Ploutz-Snyder R, Moormann AM, Rochford R.

J Med Virol. 2009 Jun;81(6):1088-93. doi: 10.1002/jmv.21485.

44.

Toll-like receptor polymorphisms in malaria-endemic populations.

Greene JA, Moormann AM, Vulule J, Bockarie MJ, Zimmerman PA, Kazura JW.

Malar J. 2009 Mar 24;8:50. doi: 10.1186/1475-2875-8-50.

45.

Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses.

Moormann AM, Heller KN, Chelimo K, Embury P, Ploutz-Snyder R, Otieno JA, Oduor M, Münz C, Rochford R.

Int J Cancer. 2009 Apr 1;124(7):1721-6. doi: 10.1002/ijc.24014.

46.

Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children.

Asito AS, Moormann AM, Kiprotich C, Ng'ang'a ZW, Ploutz-Snyder R, Rochford R.

Malar J. 2008 Nov 18;7:238. doi: 10.1186/1475-2875-7-238.

47.

Burkitt lymphoma in Uganda: 50 years of ongoing discovery.

Moormann AM, Lozada JS.

Pediatr Blood Cancer. 2009 Apr;52(4):433-4. doi: 10.1002/pbc.21840. Review. No abstract available.

PMID:
19003907
48.

Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults.

Dent AE, Bergmann-Leitner ES, Wilson DW, Tisch DJ, Kimmel R, Vulule J, Sumba PO, Beeson JG, Angov E, Moormann AM, Kazura JW.

PLoS One. 2008;3(10):e3557. doi: 10.1371/journal.pone.0003557. Epub 2008 Oct 29.

49.

Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission.

Noland GS, Hendel-Paterson B, Min XM, Moormann AM, Vulule JM, Narum DL, Lanar DE, Kazura JW, John CC.

Infect Immun. 2008 Dec;76(12):5721-8. doi: 10.1128/IAI.00591-08. Epub 2008 Sep 22.

50.

Fine specificity of neonatal lymphocytes to an abundant malaria blood-stage antigen: epitope mapping of Plasmodium falciparum MSP1(33).

Malhotra I, Wamachi AN, Mungai PL, Mzungu E, Koech D, Muchiri E, Moormann AM, King CL.

J Immunol. 2008 Mar 1;180(5):3383-90.

Supplemental Content

Loading ...
Support Center